BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2010
View Archived Issues
Schering Plough receives approval for Temodal in Japan
Read More
Natural product IDN-5706 has beneficial effects in mouse model of AD
Read More
Curemark initiates enrollment into phase III clinical trials of CM-AT in the U.S.
Read More
EMEA initiates review of Amsterdam MolecularTherapeutics' MAA for Glybera in LPLD
Read More
Dynavax Technologies reports phase Ib data on SD-101 in chronic hepatitis C
Read More
INSYS Therapeutics completes efficacy trial of fentanyl sublingual spray
Read More
Shionogi launches peramivir in Japan
Read More
Envoy Therapeutics and Merck & Co. enter into diabetes and obesity collaboration
Read More
Romiplostim appears to be safe in MDS patients with thrombocytopenia
Read More
Penwest enters into fourth research and development agreement with Otsuka
Read More
Novel modulator of mitochondrial membrane potential shows antidiabetic effects in mice
Read More
Preclinical activity of novel mitotic kinesin inhibitor supports clinical evaluation in cancer
Read More
FDA approves Novo Nordisk's Victoza for certain adults with type 2 diabetes
Read More
Ambrilia discloses HIV integrase inhibitors for the prevention and treatment of AIDS
Read More
U.S. Army claims BoNT/A LC inhibitors for the treatment of C. botulinum infection
Read More
Telik initiates phase I trial of ezatiostat in patients with myelodysplastic syndrome
Read More
Bayer Schering describes novel adenosine A1 agonists for the treatment of CAD
Read More
Concert presents alpha2-adrenoceptor agonists for motor function disorders
Read More
PI3K and mTOR inhibitors in early development at Wyeth
Read More
Roche identifies novel tachykinin NK3 receptor antagonists as antipsychotics
Read More
New protein kinase inhibitors for the treatment of cancer discovered at Plexxikon
Read More
Prometheus Laboratories acquires exclusive rights to Proleukin in the U.S.
Read More
Amgen reports results from fourth quarter of 2009
Read More
China Aoxing completes phase III registration study of tilidine for moderate to severe pain
Read More
FDA reschedules review of NDA for Theratechnologies' tesamorelin
Read More
Dainippon obtains Japanese approval for additional indication for Meropen
Read More